Format

Send to

Choose Destination
  • Showing results for patient calcium channel blockers and the risk of postpartum hemorrhage a cohort study. Your search for utpatient Calcium Channel Blockers and the Risk of Postpartum Hemorrhage: A Cohort Study retrieved no results.
BJOG. 2013 Dec;120(13):1668-76; dicussion 1676-7. doi: 10.1111/1471-0528.12428. Epub 2013 Sep 11.

Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study.

Author information

1
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Anesthesiology, Critical Care, and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Abstract

OBJECTIVE:

To determine whether outpatient exposure to calcium-channel blockers (CCBs) at the time of delivery is associated with an increased risk for postpartum haemorrhage (PPH).

DESIGN:

Cohort study.

SETTING:

United States of America.

POPULATION OR SAMPLE:

Medicaid beneficiaries.

METHODS:

We identified a cohort of 9750 patients with outpatient prescriptions for CCBs, methyldopa, or labetalol for pre-existing or gestational hypertension whose days of supply overlapped with delivery; 1226 were exposed to CCBs. The risk of PPH was compared in those exposed to CCBs to those exposed to methyldopa or labetalol. Propensity score matching and stratification were used to address potential confounding.

MAIN OUTCOME MEASURES:

The occurrence of PPH during the delivery hospitalisation.

RESULTS:

There were 27 patients exposed to CCBs (2.2%) and 232 patients exposed to methyldopa or labetalol (2.7%) who experienced PPH. After accounting for confounders, there was no meaningful association between CCB exposure and PPH in the propensity score matched (odds ratio 0.77, 95% CI 0.50-1.18) or stratified (odds ratio 0.79, 95% CI 0.53-1.19) analyses. Similar results were obtained across multiple sensitivity analyses.

CONCLUSIONS:

The outpatient use of CCBs in late pregnancy for the treatment of hypertension does not increase the risk of PPH.

KEYWORDS:

Calcium-channel blockers; hypertensive disorders of pregnancy; postpartum haemorrhage

PMID:
24020971
PMCID:
PMC3866215
DOI:
10.1111/1471-0528.12428
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center